DUBLIN–(BUSINESS WIRE)–The “Oncology
Pipeline Database – 2018” report has been added to ResearchAndMarkets.com’s
Oncology Pipeline Highlights Database – 2018, provides most up-to-date
information on key pipeline products in the global Oncology Drug market.
It covers emerging therapies for Oncology indications in active clinical
development stages including early and late stage clinical trials. The
pipeline data is presented in an excel dashboard with filtering options.
The pipeline data presented in this database helps executives for
tracking competition, identifying partners, evaluating opportunities,
formulating business development strategies, and executing in-licensing
and out-licensing deals.
- Oncology Pipeline by Indication
- Oncology Pipeline by Clinical Trial Phase
- Oncology Pipeline by Drug Mechanism Classes
- Oncology Pipeline by Company
The database presents pipeline by Oncology indications. Key indications
covered in this database include Esophageal Cancer Stomach Cancer, Colon
Cancer, Pancreatic Cancer, Malignant Melanoma, Breast Cancer, Cervical
Cancer, Ovary Cancer, Prostate Cancer, Renal Cancer, Bladder Cancer,
Brain Cancer, Hodgkin’s disease, Acute Myeloid Leukemia and Multiple
By Clinical Trial Stages:
The database provides Oncology pipeline products by clinical trial
stages including both early and late stage development – phase 3
clinical trials, phase 2 clinical trials, phase 1 clinical trials,
preclinical research, and discovery stage.
By Drug Mechanism Classes:
The database provides Oncology pipeline products by their dominant drug
mechanism class. This helps executives categorize products based on
their drug class and also assess the strengths and weaknesses of
The database provides Oncology pipeline products by the company.
For more information about this report visit https://www.researchandmarkets.com/research/l5h248/global_oncology?w=4
Laura Wood, Senior Manager
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900